Related Experiment Video
Updated: May 15, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
Antioxidant therapy: still in search of the 'magic bullet'
Sofia Benfeito1, Catarina Oliveira, Pedro Soares
1CIQ/Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto 4169-007, Portugal.
Abstract:
The therapeutic potential of natural phenolic antioxidants in human diseases associated with oxidative damage has received great attention to date. Appraisal of literature evidences that, in general, antioxidant therapy has enjoyed relative successes in preclinical studies but little benefits in human intervention studies or clinical trials. In fact, despite the huge, largely untapped potential therapeutic benefit of natural phenolic antioxidants, such as vitamins, non-flavonoid and flavonoid compounds, they appear not to be suitable drug candidates. The problem may be related, among others, to their non-drug-likeness properties. Though controversial the results obtained so far confirm the importance of exploring phenolic natural systems as safe templates for the design of new antioxidants. To support the assumption an outlook of the lead structural optimization process to improve ADME properties was given by means of natural hydroxycinnamic acids as a case study. The optimization of drug physicochemical properties and the development of appropriate delivery antioxidant systems can provide in the next future a way out to attain effective therapeutic antioxidant agents.
Insights
Natural phenolic antioxidants show promise for diseases linked to oxidative damage, but often fail in human trials due to poor drug-like properties. Optimization strategies are key to developing effective antioxidant therapies.
Area of Science:
- Pharmacology and Natural Product Chemistry
- Medicinal Chemistry
- Oxidative Stress Research
Background:
- Natural phenolic antioxidants are extensively researched for therapeutic potential against oxidative stress-related diseases.
- While preclinical studies show success, human trials yield limited benefits, suggesting issues with current antioxidant therapies.
- Natural compounds like vitamins, flavonoids, and non-flavonoids possess significant therapeutic promise but often lack suitable drug-like characteristics.
Purpose of the Study:
- To evaluate the therapeutic potential of natural phenolic antioxidants.
- To investigate the reasons for the limited success of antioxidant therapy in human studies.
- To explore strategies for optimizing natural phenolic compounds into effective drug candidates.
Main Methods:
- Literature review and appraisal of existing evidence on antioxidant therapy.
- Analysis of drug-likeness and ADME (Absorption, Distribution, Metabolism, and Excretion) properties of phenolic antioxidants.
- Case study using natural hydroxycinnamic acids for lead structural optimization.
Main Results:
- Antioxidant therapy has shown success in preclinical settings but limited efficacy in human trials.
- Non-drug-likeness properties are identified as a potential barrier to the clinical success of natural phenolic antioxidants.
- Structural optimization of phenolic compounds can improve ADME properties, as demonstrated with hydroxycinnamic acids.
Conclusions:
- Natural phenolic compounds are valuable templates for designing new antioxidants, despite current limitations.
- Improving physicochemical and ADME properties through structural optimization is crucial for developing effective therapeutic antioxidants.
- Development of advanced delivery systems alongside optimized compounds may overcome current challenges in antioxidant therapy.
Related Concept Videos
Radical Autoxidation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmaceutical Poisoning: Treatment Strategies
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...

